Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy
Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Arthritis & Rheumatism
DOI: 10.1002/art.511
Institution: Ghent University Hospital
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2006154561
